FDA grants 510(k) clearance for Boston Cell Standards’ IHControls panel

January 20, 2026

Boston Cell Standards Calibrator technology presented at The Pathological Society of Great Britain & Ireland Winter Meeting 2026

January 6, 2026

International study demonstrates the effectiveness of Boston Cell Standards Calibrators for measuring analytical sensitivity used for breast cancer diagnosis.

December 1, 2025

Calibration Transforms Accuracy in HER2-Low Breast Cancer Testing

International Study Published in Lancet: eBioMedicine BOSTON – November 19, 2025 — Boston Cell Standards today announced the publication of the CASI-01 study in Lancet: eBioMedicine...